Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
5.40
-0.10 (-1.82%)
Sep 11, 2025, 4:00 PM EDT - Market closed

Dermata Therapeutics Statistics

Total Valuation

DRMA has a market cap or net worth of $3.68 million. The enterprise value is -$2.80 million.

Market Cap3.68M
Enterprise Value -2.80M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

DRMA has 681,557 shares outstanding. The number of shares has increased by 1,442.75% in one year.

Current Share Class 681,557
Shares Outstanding 681,557
Shares Change (YoY) +1,442.75%
Shares Change (QoQ) +23.72%
Owned by Insiders (%) 15.81%
Owned by Institutions (%) 2.73%
Float 498,471

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.61
P/TBV Ratio 0.66
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.47

Current Ratio 6.47
Quick Ratio 6.32
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -231.27% and return on invested capital (ROIC) is -147.48%.

Return on Equity (ROE) -231.27%
Return on Assets (ROA) -110.91%
Return on Invested Capital (ROIC) -147.48%
Return on Capital Employed (ROCE) -187.71%
Revenue Per Employee n/a
Profits Per Employee -$1.29M
Employee Count8
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -66.46% in the last 52 weeks. The beta is 0.56, so DRMA's price volatility has been lower than the market average.

Beta (5Y) 0.56
52-Week Price Change -66.46%
50-Day Moving Average 6.27
200-Day Moving Average 9.30
Relative Strength Index (RSI) 43.11
Average Volume (20 Days) 27,420

Short Selling Information

The latest short interest is 13,002, so 1.91% of the outstanding shares have been sold short.

Short Interest 13,002
Short Previous Month 11,727
Short % of Shares Out 1.91%
Short % of Float 2.61%
Short Ratio (days to cover) 0.44

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -10.54M
Pretax Income -9.82M
Net Income -10.33M
EBITDA n/a
EBIT -10.54M
Earnings Per Share (EPS) -$16.20
Full Income Statement

Balance Sheet

The company has $6.48 million in cash and n/a in debt, giving a net cash position of $6.48 million or $9.51 per share.

Cash & Cash Equivalents 6.48M
Total Debt n/a
Net Cash 6.48M
Net Cash Per Share $9.51
Equity (Book Value) 5.61M
Book Value Per Share 8.80
Working Capital 5.61M
Full Balance Sheet

Cash Flow

Operating Cash Flow -10.96M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DRMA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,442.75%
Shareholder Yield -1,442.75%
Earnings Yield -280.64%
FCF Yield n/a

Analyst Forecast

The average price target for DRMA is $10.00, which is 85.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 85.19%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 1, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date Aug 1, 2025
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 1